Chronic Gout
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL) (NCT04762498) | Amgen | 2021-01-26 |
| A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy II (NCT04596540) | Swedish Orphan Biovitrum | 2020-11-30 |
| A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy (NCT04513366) | Swedish Orphan Biovitrum | 2020-08-18 |
| A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy (NCT03905512) | Selecta Biosciences, Inc. | 2019-05-07 |
| The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics (NCT02956278) | University of California, San Francisco | 2016-11-01 |
Track Chronic Gout automatically
Every clearance here is in the API, with alerts when new ones post.